Alkion BioInnovations
Boulogne-billancourt
About Alkion BioInnovations
Alkion BioInnovations was created in March 2017 in order to develop disruptive cannabinoid & pharmaceutical API production using large scale plant tissue production. The team works also on a new sugar replacement: a novel plant-based high intensive protein sweetener. The company won many R&D grants: I-lab, I-Nov, Plan de Relance & EIC Phase I; and other prize: La Fabrique Aviva, Netva, Wilco, IPA4SME...
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.0M
- Funding stage: Seed
- Last round: Seed (Nov 2025)
- Website: alkinnov.com
- Phone: +33 769055533
Industries & Categories
Biotechnology, Natural Resources, Nutrition
Social Profiles
Canonical: https://fsome.com/organization/alkion-bioinnovations-107471 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.